Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-14
2011-06-14
Aulakh, Charanjit S (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S018000, C546S020000
Reexamination Certificate
active
07960403
ABSTRACT:
Compounds according to formula (I):wherein A, R1, R2and R3are defined as defined herein, and the pharmaceutically acceptable salts, hydrates and solvates thereof, are useful for the modulation of CCR5 chemokine receptor activity.
REFERENCES:
patent: 5407938 (1995-04-01), Fisher et al.
patent: 5534520 (1996-07-01), Fisher et al.
patent: 5852029 (1998-12-01), Fisher et al.
patent: 2310458 (1991-06-01), None
patent: 2 310 458 (1999-06-01), None
patent: WO 95/03303 (1995-02-01), None
patent: WO 01/66546 (2001-09-01), None
patent: WO 02/13824 (2002-02-01), None
patent: WO 2004/041279 (2004-05-01), None
patent: WO 2005/007656 (2005-01-01), None
patent: WO 2005007656 (2005-01-01), None
patent: WO 2005/023809 (2005-03-01), None
patent: WO 2005/023810 (2005-03-01), None
patent: WO 2005023810 (2005-03-01), None
patent: WO 2006/000096 (2006-01-01), None
patent: WO 2006/060918 (2006-06-01), None
patent: WO 2006/060919 (2006-06-01), None
patent: WO 2007/143847 (2007-12-01), None
International Search Report for International Application No. PCT/CA2005/001878 mailed Mar. 29, 2006.
International Preliminary Report on Patentability for International Application No. PCT/CA2005/001878 issued Jun. 13, 2007.
Dr. Rolf Eberbard Nitz, et al., Arzneimittel-Forschung, pp. 357-364, Jul. 1955.
Por A. Garcia Sacristan, et al., Arch. De. Farmacol y Toxicol, 1977, pp. 57-66.
George W. Smith, et al., Journal of the American Chemical Society, vol. 77, pp. 3541-3543, Jul. 5, 1955.
Abstract of Dr. Rolf Eberbard Nitz, et al., Arzneimittel-Forschung, pp. 357-364, Jul. 1955.
Abstract of Por A. Garcia Sacristan, et al., Arch. De. Farmcol y Toxicol, 1977, pp. 57-66.
International Search Report for International Application No. PCT/CA2007/001062 mailed Sep. 6, 2007.
Supplementary European Search Report for European Application No: 05 81 9431.7—2117/ 1831222 of Sep. 18, 2009.
Written Opinion of the International Searching Authority for International Application No. PCT/CA2005/001877 mailed Mar. 29, 2006.
Extended European Search Report in European Application No. 05 819 950.6—2101 / 1824853 dated Oct. 5, 2010.
International Search Report for International Application No: PCT/CA2005/001877 mailed Mar. 29, 2006.
International Preliminary Report on Patentability for International Application No. PCT/CA2005/001877 issued Jun. 13, 2007.
Fujio, M. et al. “Spiro compounds, process for preparing the same and use thereof as drugs”, Abstract of WO2001066546 A1. Publication date: Sep. 13, 2001. Application No: WO2001JP1793A. Filing date: Mar. 7, 2001. (Thomson Innovation Record View).
Bellanto, J. et al. “Raman spectra and hydrogen bonding of azabicyclospirohydantoins”, Accession No. 1981:207963, CAPULUS 77699151 (1980).
Bellanto, J. et al. “Hydrogen bonding and IR spectra of N-substituted granatanine- and nortropane-3-spiro-5'-hydantoins”, Accession No. 1980:40819, CAPULUS 72402245 (1979).
Castro, V. et al. “Local-anesthetic-antiinflammatory activity of some spiro[hydantoin] derivatives of N-substituted nortropane.”, Accession No. 1978:590809, CAPULUS 64192796 (1978).
Blais Charles
Bubenik Monica
Chan Chun Kong Laval
Courchesne Marc
Moinet Christophe
Aulakh Charanjit S
Millen White Zelano & Branigan P.C.
Virochem Pharma Inc.
LandOfFree
Spirotropane compounds and methods for the modulation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spirotropane compounds and methods for the modulation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spirotropane compounds and methods for the modulation of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2733975